NOD2/CARD15 Variants Are Not a Risk Factor for Clinical Outcome after Nonmyeloablative Allogeneic Stem Cell Transplantation

Hanneke M. van der Straaten*, Martine M. Paquay, Marcel G. J. Tilanus, Nan van Geloven, Leo F. Verdonck, Cynthia Huisman

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

9 Citations (Web of Science)
Original languageEnglish
Pages (from-to)1231-1236
JournalBiology of Blood and Marrow Transplantation
Volume17
Issue number8
DOIs
Publication statusPublished - Aug 2011

Keywords

  • NOD2/CARD15
  • Polymorphisms
  • Nonmyeloablative allogeneic stem cell transplantation
  • SNP

Cite this